Commentary: What's wrong with ghostwriting?

Bioethics

Volumn 24, Issue 6, 2010, Pages 284-286

  Elliott, Carl ^a   Landa, Amy Snow ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DRUG INDUSTRY; ETHICS; GOVERNMENT REGULATION; HUMAN; MARKETING; MEDICAL RESEARCH; NOTE; PUBLICATION; PUBLISHING; WRITING;

AUTHORSHIP; BIOMEDICAL RESEARCH; DRUG INDUSTRY; GOVERNMENT REGULATION; HUMANS; MARKETING; PERIODICALS AS TOPIC; PLAGIARISM; PUBLISHING; WRITING;

EID: 77956004474     PISSN: 02699702     EISSN: 14678519     Source Type: Journal    
DOI: 10.1111/j.1467-8519.2010.01828.x     Document Type: Note

References (6)

1. R. Smith. 2005 Medical Journals are an Extension of the Marketing Arm of Pharmaceutical Companies. PLoS Med 2005; 2(5): e138.
2. T. Anekwe. Profits and Plagarism: The Case of Medical Ghostwriting. Bioethics 2010; 24(6): 267-272.
3. S. Sismondo & M. Doucet. M Publication Ethics and the Ghost Management of Medical Publication. Bioethics 2010; 24(6): 273-283.
4. J. Habermas. 1989. The structural transformation of the public sphere. London: Polity: 193-194.
5. L. Salter. The Communicative Structures of Journalism and Public Relations. Journalism 2005; 6(1): 101.
6. D. Healy. 2004. Let them eat Prozac. New York: New York University Press; L.K. Altman, Inside Medical Journals, a Rising Quest for Profits. The New York Times August 24: Sect D 7. 1999.